 | • レポートコード：MRC2302F0142 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、222ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に384.93百万ドルであった世界の心臓ホルターモニター市場規模が、2022年に424.32百万ドルになり、2027年まで年平均10.40%で成長して697.31百万ドルまで拡大すると予測しています。本レポートは、心臓ホルターモニターの世界市場について調査し、市場の動向を明らかにした資料であり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、コンポーネント別（ホルター解析装置、ホルターソフトウェア、有線ホルター、無線ホルター）分析、製品別（12チャンネル、2チャンネル、3チャンネル）分析、エンドユーザー別（外来外科センター、診療所、在宅医療装置、病院）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など以下の構成でまとめています。また、AliveCor, Inc.、Applied Cardiac Systems、Bardy Diagnostics, Inc.、Biomedical Instruments Co., Ltd.、BTL、Cardiac Insight Inc.、Cardio Labs、CardioNet / Braemar、EB Neuro、FUKUDA DENSHI CO.,LTD.、GE Healthcare、Hemodynamics Companyなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の心臓ホルターモニター市場規模：コンポーネント別 - ホルター解析装置における市場規模 - ホルターソフトウェアにおける市場規模 - 有線ホルターにおける市場規模 - 無線ホルターにおける市場規模 ・世界の心臓ホルターモニター市場規模：製品別 - 12チャンネル心臓ホルターモニターの市場規模 - 2チャンネル心臓ホルターモニターの市場規模 - 3チャンネル心臓ホルターモニターの市場規模 ・世界の心臓ホルターモニター市場規模：エンドユーザー別 - 外来外科センターにおける市場規模 - 診療所における市場規模 - 在宅医療装置における市場規模 - 病院における市場規模 ・世界の心臓ホルターモニター市場規模：地域別 - 南北アメリカの心臓ホルターモニター市場規模 アメリカの心臓ホルターモニター市場規模 カナダの心臓ホルターモニター市場規模 ブラジルの心臓ホルターモニター市場規模 … - アジア太平洋の心臓ホルターモニター市場規模 日本の心臓ホルターモニター市場規模 中国の心臓ホルターモニター市場規模 インドの心臓ホルターモニター市場規模 韓国の心臓ホルターモニター市場規模 台湾の心臓ホルターモニター市場規模 … - ヨーロッパ/中東/アフリカの心臓ホルターモニター市場規模 イギリスの心臓ホルターモニター市場規模 ドイツの心臓ホルターモニター市場規模 フランスの心臓ホルターモニター市場規模 ロシアの心臓ホルターモニター市場規模 … - その他地域の心臓ホルターモニター市場規模 ・競争状況 ・企業情報 |
The Global Cardiac Holter Monitor Market size was estimated at USD 384.93 million in 2021 and expected to reach USD 424.32 million in 2022, and is projected to grow at a CAGR 10.40% to reach USD 697.31 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Cardiac Holter Monitor to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Component, the market was studied across Holter Analysis System, Holter Software, Wired Holter, and Wireless Holter.
Based on Product, the market was studied across -Channel, 12-Channel, 2-Channel, and 3-Channel.
Based on End-User, the market was studied across Ambulatory Surgical Centers, Clinics, Homecare Settings, and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cardiac Holter Monitor market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Holter Monitor Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Holter Monitor Market, including AliveCor, Inc., Applied Cardiac Systems, Bardy Diagnostics, Inc., Biomedical Instruments Co., Ltd., BTL, Cardiac Insight Inc., Cardio Labs, CardioNet / Braemar, EB Neuro, FUKUDA DENSHI CO.,LTD., GE Healthcare, Hemodynamics Company, HolterCare, iRhythm Technologies, LifeWatch, Medicomp, MidMark, Mortara Instruments, Nihon Kohden Corporation, Norav, Schiller AG, ScottCare Corporation, Spacelabs Healthcare, United Cardiac Service, VitalConnect, and Welch Allyn.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Cardiac Holter Monitor Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cardiac Holter Monitor Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Holter Monitor Market?
4. What is the competitive strategic window for opportunities in the Global Cardiac Holter Monitor Market?
5. What are the technology trends and regulatory frameworks in the Global Cardiac Holter Monitor Market?
6. What is the market share of the leading vendors in the Global Cardiac Holter Monitor Market?
7. What modes and strategic moves are considered suitable for entering the Global Cardiac Holter Monitor Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population and prevalence of atrial fibrillation
5.1.1.2. Increasing prevalence of cardiovascular disorders worldwide
5.1.1.3. Growing shift toward ambulatory monitoring devices
5.1.2. Restraints
5.1.2.1. Dearth of skilled and trained professional
5.1.3. Opportunities
5.1.3.1. Technological advancements in the field of telemetry
5.1.3.2. Ongoing need for early detection of CVDs and demand for wearable devices to monitor ECG
5.1.4. Challenges
5.1.4.1. Rising cost owing to the use of devices
5.2. Cumulative Impact of COVID-19
6. Cardiac Holter Monitor Market, by Component
6.1. Introduction
6.2. Holter Analysis System
6.3. Holter Software
6.4. Wired Holter
6.5. Wireless Holter
7. Cardiac Holter Monitor Market, by Product
7.1. Introduction
7.2. -Channel
7.3. 12-Channel
7.4. 2-Channel
7.5. 3-Channel
8. Cardiac Holter Monitor Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Homecare Settings
8.5. Hospitals
9. Americas Cardiac Holter Monitor Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cardiac Holter Monitor Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cardiac Holter Monitor Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AliveCor, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Applied Cardiac Systems
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bardy Diagnostics, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Biomedical Instruments Co., Ltd.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. BTL
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cardiac Insight Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Cardio Labs
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. CardioNet / Braemar
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. EB Neuro
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. FUKUDA DENSHI CO.,LTD.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. GE Healthcare
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Hemodynamics Company
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. HolterCare
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. iRhythm Technologies
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. LifeWatch
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Medicomp
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. MidMark
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Mortara Instruments
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Nihon Kohden Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Norav
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Schiller AG
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. ScottCare Corporation
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Spacelabs Healthcare
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. United Cardiac Service
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. VitalConnect
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. Welch Allyn
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing